AN
Anebulo Pharmaceuticals, Inc.
ANEB · OTC
$0.39 +8.76% (+$0.03)
1M +19.53%
Market Cap $15.9M
P/E Ratio -
Div. Yield -
ROE 74.58%
Bulios Fair Price
$0.51
30.8% upside
Trenutna cena
$0.39
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ANEB trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
87 /100
Cheap P/B 2.00x
EV/EBITDA N/A
P/S N/A
Growth
0 /100
Declining Book val. growth 8.20%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 74.58%
ROA 84.68%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 16.71x
Int. coverage -25.82x
Debt/Equity 0.00x
Stability
34 /100
Moderate EPS volatility 51.61%
Profitable years 0
Beta -1.82x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ANEB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Richard Anthony Cunningham
Employees
3
Headquarters
Lakeway
Prihajajoči dogodki
23 SEP.
Earnings
Upcoming earnings report